HCG18 and cardiovascular disorder: In conclusion, lncRNA-HCG18 inhibited the proliferation of cardiac fibroblasts through the hsa-miR-133a/EGFR axis, which provided a further elucidation of the theoretical basis for the molecular and biochemical mechanisms of the direct proliferation of cardiac fibroblasts in cardiovascular diseases.